Human HTT (Huntingtin) knockout HeLa cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
HTT KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon21.
View Alternative Names
AI256365, C430023I11Rik, HD protein, HDH, HD_HUMAN, HUNTINGTON CHOREA, Huntingtin, Huntington disease protein, Huntington's disease protein homolog, IT 15, OTTMUSP00000026909, ZHD
- WB
Lab
Western blot - Human HTT (Huntingtin) knockout HeLa cell lysate (AB256946)
Lane 1 : Wild-type HeLa cell lysate (20μg)
Lane 2 : HTT knockout HeLa cell lysate (20μg)
Lanes 1- 2 : Merged signal (red and green). Green - ab45169 observed at 348 kDa. Red - loading control ab7291 observed at 50 kDa.
ab45169 Anti-Huntingtin antibody [EP867Y] was shown to specifically react with Huntingtin in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265976 (knockout cell lysate ab256946) was used. Wild-type and Huntingtin knockout samples were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab45169 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 10000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Huntingtin antibody [EP867Y] (<a href='/en-us/products/primary-antibodies/huntingtin-antibody-ep867y-ab45169'>ab45169</a>) at 1/10000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
HTT knockout HeLa cell lysate at 20 µg
Predicted band size: 348 kDa
Observed band size: 348 kDa
false
- WB
Lab
Western blot - Human HTT (Huntingtin) knockout HeLa cell lysate (AB256946)
Lane 1 : Wild-type HeLa cell lysate (20μg)
Lane 2 : HTT knockout HeLa cell lysate (20μg)
Lanes 1- 2 : Merged signal (red and green). Green - ab109115 observed at 348 kDa. Red - loading control ab7291 observed at 50 kDa.
ab109115 Anti-Huntingtin antibody [EPR5526] was shown to specifically react with Huntingtin in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265976 (knockout cell lysate ab256946) was used. Wild-type and Huntingtin knockout samples were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab109115 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 10000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Huntingtin antibody [EPR5526] (<a href='/en-us/products/primary-antibodies/huntingtin-antibody-epr5526-ab109115'>ab109115</a>) at 1/10000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
HTT knockout HeLa cell lysate at 20 µg
Predicted band size: 348 kDa,43 kDa,52 kDa,55 kDa,56 kDa
Observed band size: 348 kDa
false
- Sanger seq
Unknown
Sanger Sequencing - Human HTT (Huntingtin) knockout HeLa cell lysate (AB256946)
Homozygous : 1 bp deletion in exon21
Reactivity data
Product details
Western blot data indicates that the CRISPR gene edit may have resulted in a truncation of the protein of interest. Please see data images.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com